Position in PTCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$336,743,224
+$68,133,208 QoQ
Shares Held
4,128,273
+4.7% QoQ
Ownership
4.95%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#6
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 88%
None 12%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. PTCT ranks #19 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in PTCT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $336,743,224 | 4,128,273 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $268,610,016 | 3,942,610 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $293,766,181 | 3,867,380 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $301,855,644 | 4,918,619 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $229,261,696 | 4,694,138 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $276,161,001 | 5,419,172 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $216,090,728 | 4,787,123 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $292,822,840 | 7,892,799 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $251,019,168 | 8,208,606 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $258,946,522 | 8,901,565 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $270,545,575 | 9,816,603 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $211,464,969 | 9,436,188 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $276,001,420 | 6,786,364 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $338,968,149 | 6,997,691 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $283,637,717 | 7,430,907 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $376,051,310 | 7,491,062 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $281,762,206 | 7,033,505 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $304,096,682 | 8,150,541 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $324,815,518 | 8,155,047 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $326,213,631 | 8,766,827 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $369,075,938 | 8,731,392 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $435,163,401 | 9,190,357 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $569,951,781 | 9,338,879 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $442,850,406 | 9,472,736 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $407,122,485 | 8,023,699 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $278,284,671 | 6,238,168 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||